Proteomic analysis of muscle affected by motor neuron degeneration: The wobbler mouse model of amyotrophic lateral sclerosis

Biochemical and Biophysical Research Communications

Volumn 406, Issue 4, 2011, Pages 595-600

  Staunton, Lisa ^a   Jockusch, Harald ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

Amyotrophic lateral sclerosis; DIGE; Motor neuron disease; Muscle proteomics; Muscular atrophy; Wobbler

Indexed keywords

ACTIN; ACTININ; ALPHA ACTININ; ALPHA ACTININ 3; COPPER ZINC SUPEROXIDE DISMUTASE; DESMIN; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE DEACETYLASE 5; MESSENGER RNA; MYOGLOBIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; TROPONIN C;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; GEL ELECTROPHORESIS; INTERMEDIATE FILAMENT; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN METABOLISM; PROTEOMICS; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; MICE; MICE, INBRED STRAINS; MOTOR NEURONS; MUSCLE, SKELETAL; NERVE DEGENERATION; PROTEOMICS;

ANIMALIA; MUS;

EID: 79953028728     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.099     Document Type: Article

References (35)

1. Wood-Allum C., Shaw P.J. Motor neurone disease: a practical update on diagnosis and management. Clin. Med. 2010, 10:252-258.
2. Van Damme P., Robberecht W. Recent advances in motor neuron disease. Curr. Opin. Neurol. 2009, 22:486-492.
3. Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009, 4:4:3.
4. Orrell R.W. Motor neuron disease: systematic reviews of treatment for ALS and SMA. Br. Med. Bull. 2010, 93:145-159.
5. R.G. Miller, J.D. Mitchell, M. Lyon, D.H. Moore, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst. Rev. 1 (2007) CD001447.
6. Tovar-Y-Romo L.B., Santa-Cruz L.D., Tapia R. Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis. Mol. Neurodegener. 2009, 4:4:31.
7. Duchen L.W., Strich S.J. An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. J. Neurol. Neurosurg. Psychiatry 1968, 31:535-542.
8. Kaupmann K., Simon-Chazottes D., Guenet J.L., Jockusch H. Wobbler, a mutation affecting motoneuron survival and gonadal functions in the mouse, maps to proximal chromosome 11. Genomics 1992, 13:39-43.
9. Schmitt-John T., Drepper C., Mussmann A., Hahn P., Kuhlmann M., Thiel C., Hafner M., Lengeling A., Heimann P., Jones J.M., Meisler M.H., Jockusch H. Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 2005, 37:1213-1215.
10. Heimann P., Laage S., Jockusch H. Defect of sperm assembly in a neurological mutant of the mouse, wobbler (WR). Differentiation 1991, 47:77-83.
11. Perez-Victoria F.J., Abascal-Palacios G., Tascon I., Kajava A., Magadan J.G., Pioro E.P., Bonifacino J.S., Hierro A. Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex. Proc. Natl. Acad. Sci. USA 2010, 107:12860-12865.
12. Meisler M.H., Russ C., Montgomery K.T., Greenway M., Ennis S., Hardiman O., Figlewicz D.A., Quenneville N.R., Conibear E., Brown R.H. Evaluation of the Golgi trafficking protein VPS54 (wobbler) as a candidate for ALS. Amyotroph. Lateral Scler. 2008, 9:141-148.
13. Bartsch J.W., Wildeboer D., Koller G., Naus S., Rittger A., Moss M.L., Minai Y., Jockusch H. Tumor necrosis factor-alpha (TNF-alpha) regulates shedding of TNF-alpha receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J. Neurosci. 2010, 30:12210-12218.
14. Iwamoto K., Yoshii Y., Ikeda K. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice. Amyotroph. Lateral Scler. 2009, 10:405-409.
15. Ohlendieck K. Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging. Expert Rev. Proteomics 2010, 7:283-296.
16. Bowser R., Cudkowicz M., Kaddurah-Daouk R. Biomarkers for amyotrophic lateral sclerosis. Expert Rev. Mol. Diagn. 2006, 387-398.
17. Rozen S., Cudkowicz M.E., Bogdanov M., Matson W.R., Kristal B.S., Beecher C., Harrison S., Vouros P., Flarakos J., Vigneau-Callahan K., Matson T.D., Newhall K.M., Beal M.F., Brown R.H., Kaddurah-Daouk R. Metabolomic analysis and signatures in motor neuron disease. Metabolomics 2005, 1:101-108.
18. Ryberg H., Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev. Proteomics 2008, 5:249-262.
19. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown R.H., Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95:1461-1471.
20. Pasinetti G.M., Ungar L.H., Lange D.J., Yemul S., Deng H., Yuan X., Brown R.H., Cudkowicz M.E., Newhall K., Peskind E., Marcus S., Ho L. Identification of potential CSF biomarkers in ALS. Neurology 2006, 66:1218-1222.
21. Ryberg H., An J., Darko S., Lustgarten J.L., Jaffa M., Gopalakrishnan V., Lacomis D., Cudkowicz M., Bowser R. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve 2010, 42:104-111.
22. Bastone A., Fumagalli E., Bigini P., Perini P., Bernardinello D., Cagnotto A., Mereghetti I., Curti D., Salmona M., Mennini T. Proteomic profiling of cervical and lumbar spinal cord reveals potential protective mechanisms in the wobbler mouse, a model of motor neuron degeneration. J. Proteome Res. 2009, 8:5229-5240.
23. Zhai J., Strom A.L., Kilty R., Venkatakrishnan P., White J., Everson W.V., Smart E.J., Zhu H. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J. 2009, 276:3308-3323.
24. Laage S., Zobel G., Jockusch H. Astrocyte overgrowth in the brain stem and spinal cord of mice affected by spinal atrophy. Wobbler. Dev. Neurosci. 1988, 10:190-198.
25. O'Connell K., Ohlendieck K. Proteomic DIGE analysis of the mitochondria-enriched fraction from aged rat skeletal muscle. Proteomics 2009, 9:5509-5524.
26. Lewis C., Ohlendieck K. Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem. Biophys. Res. Commun. 2010, 396:1024-1029.
27. Sedehizade F., Klocke R., Jockusch H. Expression of nerve-regulated genes in muscles of mouse mutants affected by spinal muscular atrophies and muscular dystrophies. Muscle Nerve 1997, 20:186-194.
28. Agbulut O., Noirez P., Butler-Browne G., Jockusch H. Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. FEBS Lett. 2004, 561:191-194.
29. Kandarian S.C., Jackman R.W. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006, 33:155-165.
30. Toigo M., Donohoe S., Sperrazzo G., Jarrold B., Wang F., Hinkle R., Dolan E., Isfort R.J., Aebersold R. ICAT-MS-MS time course analysis of atrophying mouse skeletal muscle cytosolic subproteome. Mol. Biosyst. 2005, 1:229-241.
31. Li Z.B., Lehar M., Samlan R., Flint P.W. Proteomic analysis of rat laryngeal muscle following denervation. Proteomics 2005, 5:4764-4776.
32. Sun H., Liu J., Ding F., Wang X., Liu M., Gu X. Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J. Muscle Res. Cell. Motil. 2006, 27:241-250.
33. Seo Y., Lee R., Park K., Bae K., Choi I. A proteomic assessment of muscle contractile alterations during unloading and reloading. J. Biochem. 2006, 139:71-80.
34. Moriggi M., Cassano P., Vasso M., Capitanio D., Fania C., Musicco C., Pesce V., Gadaleta M.N., Gelfi C.A. DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-carnitine supplementation. Proteomics 2008, 8:3588-3604.
35. Ferreira R., Vitorino R., Neuparth M.J., Appell H.J., Duarte J.A., Amado F. Proteolysis activation and proteome alterations in murine skeletal muscle submitted to 1 week of hindlimb suspension. Eur. J. Appl. Physiol. 2009, 107:553-563.